Cirrhosis, Liver Clinical Trials in Cleveland, Ohio

5 studies are recruiting for cirrhosis, liver in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

    Loss of skeletal muscle mass or sarcopenia is the most common and potentially reversible complication in cirrhosis that increases morbidity and mortality before, during and after liver transplantation. No proven treatments exist for the prevention or reversal of sarcopenia in cirrhosis, primarily b…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    Cleveland Clinic Foundation, Cleveland, Ohio
    Run by
    The Cleveland Clinic

    See if you can join NCT03208868 on ClinicalTrials.gov

  2. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

    This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    13 in total
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    See if you can join NCT05832229 on ClinicalTrials.gov

  3. HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis

    Loss of skeletal muscle mass or sarcopenia is the most common and potentially reversible complication in cirrhosis that increases morbidity and mortality before, during and after liver transplantation. No proven treatments exist for the prevention or reversal of sarcopenia in cirrhosis, primarily b…

    Stage
    Not phased
    Ages
    21 to 65
    Site
    Cleveland Clinic, Cleveland, Ohio
    Run by
    The Cleveland Clinic

    See if you can join NCT05166499 on ClinicalTrials.gov

  4. Molecular Mechanism of Exercise in Cirrhosis

    This study aims to investigate the effects of 12 weeks of resistance or endurance exercise on patients with cirrhosis. Cirrhotic patients are prone to muscle loss (sarcopenia) and ammonia build up due to liver dysfunction. The liver which in healthy patients is able to process ammonia through ureag…

    Stage
    Not phased
    Ages
    21 to 65
    Site
    Cleveland Clinic, Cleveland, Ohio
    Run by
    The Cleveland Clinic

    See if you can join NCT05982769 on ClinicalTrials.gov

  5. Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

    This 2-part study will evaluate PHIN-214 given as a single one-time dose (Part 1) and in multiple doses (given as daily doses for 28-days) (in Part 2). Specifically, this study evaluates PHIN-214, to determine the safety, tolerability, and pharmacokinetic effects of PHIN-214, and to establish the m…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Cleveland Clinic, Cleveland, Ohio
    Locations
    9 in total
    Run by
    PharmaIN

    See if you can join NCT05490888 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.